Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants

Mansoura University

Overview

prospective single center pilot randomized open label clinical trial, conducted at the Neonatal care unit of Mansoura University Children's To assess the efficacy and safety of aluminum foil use in combination with phototherapy compared with phototherapy alone for pathological unconjugated hyperbilirubinaemia in full term newborn We enrolled 234 infants in the study who fulfilled the inclusion criteria and were randomly assigned to treatment groups, either conventional phototherapy with aluminum foil or conventional phototherapy alone.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Conditions

Neonatal Jaundice

Interventions

Phototherapy with aluminum foilDEVICE

Phototherapy without aluminum foilDEVICE

Eligibility

Sex: ALLMax age: 28 Days

Medical Language ↔ Plain English

Inclusion Criteria: * Appropriate for gestational age full-term infants with pathological unconjugated hyperbilirubinaemia who are candidate for photo therapy according to American academy guidelines Exclusion Criteria: * Preterm infants, newborn infant with congenital malformations, conjugated hyperbilirubinamia, small for gestational age, in need of exchange transfusion, and skin abrasions or infections

Outcomes

Primary Outcomes

Total serum bilirubin

measurement of Total serum bilirubin (mg/dl)

Time frame: 8 hours of treatment

Total serum bilirubin

measurement of Total serum bilirubin (mg/dl)

Time frame: 24 hours of treatment

Total serum bilirubin

measurement of Total serum bilirubin (mg/dl)

Time frame: 48 hours of treatment

Secondary Outcomes

duration of photo therapy

duration of photo therapy in hours

Time frame: average 48 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.